Key Stats for CRH Stock
- Past-Week Performance: +0.7%
- 52-Week Range: $76.8 to $131.6
- Current Price: $100.5
What Happened?
Twelve consecutive years of margin expansion at CRH, North America’s largest infrastructure materials supplier, culminated in record adjusted EBITDA of $7.7 billion for 2025, even as the stock sits 24% below its 52-week high of $131.55 at $100.47.
On February 19, CRH reported full-year revenue of $37.4 billion, up 5%, and adjusted free cash flow of $5 billion, up 18%, while guiding 2026 adjusted EBITDA to $8.1 billion to $8.5 billion, a range that implies an 11th straight year of top-line and profit growth.
Adjusted free cash flow conversion reached 130% of net income in 2025 driven by pricing discipline across aggregates and cement, the two raw materials that feed every other product CRH sells.
On March 11, the UK’s Competition and Markets Authority cleared CRH’s acquisition of Gibson, adding to a $4.1 billion, 38-deal acquisition spree in 2025 that included the $1.25 billion purchase of Eco Material, a leading supplier of supplemental cementitious materials used as lower-carbon substitutes for traditional cement.
Jim Mintern, Chief Executive Officer, stated on the Q4 2025 earnings call that “2025 was also a busy year investing for future growth and value creation,” anchoring a $4.1 billion, 38-acquisition program that included the $1.25 billion purchase of Eco Material, a supplemental cementitious materials supplier whose integration management calls ahead of schedule.
Just two weeks ago, CRH’s planned April 20 delisting from the London Stock Exchange, combined with a $300 million active buyback program running through April 28 and a 5% dividend increase to $0.39 per share quarterly, consolidates the company’s identity as a NYSE-listed, U.S.-infrastructure-first compounder entering what management projects as a record federal highway funding year.
Backed by $40 billion of projected financial capacity through 2030, a $300 million active buyback running through April 28, and 50% of federal IIJA highway funds still undeployed, CRH enters what management projects as a record federal funding year as the dominant NYSE-listed U.S. infrastructure compounder.
Wall Street’s Take on CRH Stock
CRH’s February 19 record results, capped by $7.7 billion adjusted EBITDA and 130% free cash flow conversion, confirm that the infrastructure materials compounder’s margin engine is accelerating into the strongest federal funding backdrop in U.S. history.
The TIKR model projects CRH’s EBITDA growing from $7.7 billion in 2025 to $8.3 billion in 2026 and $11.5 billion by 2030, supported by 6% to 7.6% annual revenue growth driven by IIJA deployment, record DOT budgets, and Eco Material’s projected $200 million net EBITDA contribution in 2026.
Fifteen analysts currently cover CRH, with 15 buys, 5 outperforms, 4 holds, 1 underperform, and 1 sell, producing a mean price target of $142.41, implying 41.7% upside from the current price of $100.47.
Analyst price targets range from $105 on the low end to $163 on the high, where the bull case prices in full IIJA monetization and sustained data center demand, and the bear case reflects execution risk on Eco Material integration and subdued residential construction.
What Does the Valuation Model Say?
The TIKR mid-case target of $173.14, implying 72.3% total return and a 12% annualized IRR through December 2030, assumes 6.7% revenue CAGR and net income margins expanding to 11.6%, underpinned by 13 consecutive years of margin growth and $40 billion in projected financial capacity.
At $100.47, the market prices CRH as a cyclical materials stock despite 130% free cash flow conversion and 12 unbroken years of margin expansion that prove otherwise.
CRH’s $5 billion in 2025 free cash flow, growing to a modeled $3.3 billion on a lower FCF margin basis in 2026 before recovering to $4.8 billion by 2030, directly supports the TIKR $173.14 target’s assumption of sustained capital returns.
Two directors purchased shares on March 13, and CRH continues buying stock at prices between $99 and $118 under its $300 million program, signaling management conviction that the current price misrepresents intrinsic value.
Any sustained deterioration in aggregates pricing, which drove 6% mix-adjusted growth in 2025 and underpins the margin expansion model, would break the TIKR model’s core EBITDA margin trajectory toward 22% by 2030.
CRH’s Q1 results, expected in April, will confirm whether aggregates volumes and pricing are tracking the low-single-digit volume and mid-single-digit price growth management guided for 2026.
Should You Invest in CRH plc?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up CRH stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track CRH plc alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze CRH stock on TIKR for Free →
